γ-Synuclein as a marker of retinal ganglion cells

Molecular Vision

Volumn 14, Issue , 2008, Pages 1540-1548

  Surgucheva, Irina ^a,b   Weisman, Alejandra D ^c   Goldberg, Jeffrey L ^c   Shnyra, Alexander ^d   Surguchov, Andrei ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA SYNUCLEIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; THY 1 ANTIGEN; TRANSCRIPTION FACTOR POU4F1;

ADULT; AGED; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL IMMORTALIZATION; CELL SWELLING; CONTROLLED STUDY; CYTOPLASM; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; OPTIC NERVE FIBER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RETINA GANGLION CELL; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

AGED; ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION; HUMANS; INFANT; MIDDLE AGED; OPTIC NERVE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTOR BRN-3A;

EID: 50549086818     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Quigley HA. Glaucoma: macrocosm to microcosm the Friedenwald lecture. Invest Ophthalmol Vis Sci 2005; 46:2662-70.
2. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005; 46:175-82.
3. Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol 1981; 99:137-43.
4. Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol 1995; 23:85-91.
5. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36:774-86.
6. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80:389-93.
7. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci 1998; 18:8936-46.
8. Li Y, Schlamp CL, Nickells RW. Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci 1999; 40:1004-8.
9. Huang W, Fileta J, Guo Y, Grosskreutz CL. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma. Curr Eye Res 2006;31:265-71.
10. Xiang M, Zhou L, Macke JP, Yoshioka T, Hendry SH, Eddy RL, Shows TB, Nathans J. The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci 1995; 15:4762-85.
11. Gan L, Wang SW, Huang Z, Klein WH. POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev Biol 1999; 210:469-80.
12. Wang SW, Gan L, Martin SE, Klein WH. Abnormal polarization and axon outgrowth in retinal ganglion cells lacking the POU-domain transcription factor Brn-3b. Mol Cell Neurosci 2000;16:141-56.
13. Surgucheva I, McMahan B, Ahmed F, Tomarev S, Wax MB, Surguchov A. Synucleins in glaucoma: implication of -synuclein in glaucomatous alterations in the optic nerve. J Neurosci Res 2002; 68:97-106.
14. Barres BA, Silverstein BE, Corey DP, Chun LL. Immunological, morphological, and electrophysiological variation among retinal ganglion cells purified by panning. Neuron 1988; 1:791-803.
15. Farkas RH, Qian J, Goldberg JL, Quigley HA, Zack DJ. Gene expression profiling of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45:2503-13.
16. Wang JT, Kunzevitzky NJ, Dugas JC, Cameron M, Barres BA, Goldberg JL. Disease gene candidates revealed by expression profiling of retinal ganglion cell development. J Neurosci 2007;27:8593-603.
17. Meyer-Franke A, Kaplan MR, Pfrieger FW, Barres BA. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 1995; 15:805-19.
18. Geller HM, Dubois-Dalcq M. Antigenic and functional characterization of a rat central nervous system-derived cell line immortalized by a retroviral vector. J Cell Biol 1988; 107:1977-86.
19. Aoun P, Simpkins JW, Agarwal N. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci 2003;44:2999-3004.
20. Surgucheva I, Park BC, Yue BY, Tomarev S, Surguchov A. Interaction of myocilin with gamma-synuclein affects its secretion and aggregation. Cell Mol Neurobiol 2005; 25:1009-33.
21. Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF, Agarwal N. Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 2001; 86:1-12.
22. Surgucheva IG, Sivak JM, Fini ME, Palazzo RE, Surguchov AP. Effect of γ-synuclein over-expression on matrix metalloproteinases in retinoblastoma Y79 cells. Arch Biochem Biophys 2003; 410:167-76.
23. Surguchov A, McMahon B, Masliah E, Surgucheva I. Synucleins in ocular tissues. J Neurosci Res 2001; 65:68-77.
24. Badea TC, Nathans J. Quantitative analysis of neuronal morphologies in the mouse retina visualized by using a genetically directed reporter. J Comp Neurol 2004; 480:331-51.
25. Doi M, Uji Y, Yamamura H. Morphological classification of retinal ganglion cells in mice. J Comp Neurol 1995; 356:368-86.
26. Liu CJ, Chaturvedi N, Barnstable CJ, Dreyer EB. Retinal Thy1 expression during development. Invest Ophthalmol Vis Sci 1996; 37:1469-73.
27. Buchman VL, Hunter HJ, Pinõn LG, Thompson J, Privalova EM, Ninkina NN, Davies AM. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J Neurosci 1998; 18:9335-41.
28. Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR, Vetter ML, Marsh-Armstrong N, Horner PJ. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 2008; 28:2735-44.
29. Buchman VL, Adu J, Pinõn L, Ninkina N, Davies A. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci 1998; 1:101-3.
30. Clayton DF, George JM. Synucleins in synaptic plasticity and neuro-degenerative disorders. J Neurosci Res 1999; 58:120-9.
31. George JM. The synucleins. Genome Biol 2002; 3:1-6.
32. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N. Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis 2007; 13:949-61.
33. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J Biol Chem 1998; 273:26292-4.
34. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Homer PJ, Marsh-Armstrong N. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008; 28:548-61.
35. Chintala SK, Zhang X, Austin JS, Fini ME. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002; 277:47461-8.
36. Pronin AN, Morris AJ,'Surguchov A, Benovic JL. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J Biol Chem 2000; 275:26515-22.
37. Dorval V, Fraser PE. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem 2006; 281:9919-24.
38. Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, Lee VM, Ischiropoulos H. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. J Biol Chem 2004; 279:47746-53.
39. Surgucheva I, Surguchov A. Cell-type specific promoter activity and binding to transcription factors. J Mol Neurosci 2008; 35:267-71.